News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,065 Results
Type
Article (44053)
Company Profile (313)
Press Release (684699)
Multimedia
Podcasts (75)
Webinars (13)
Section
Business (211894)
Career Advice (2098)
Deals (36402)
Drug Delivery (100)
Drug Development (82306)
Employer Resources (176)
FDA (16743)
Job Trends (15329)
News (356203)
Policy (33424)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (20)
Allergies (90)
Alliances (52486)
ALS (98)
Alzheimer's disease (1411)
Antibody-drug conjugate (ADC) (144)
Approvals (16738)
Artificial intelligence (296)
Autoimmune disease (23)
Automation (17)
Bankruptcy (365)
Best Places to Work (11930)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (222)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (297)
Cancer (2363)
Cardiovascular disease (183)
Career advice (1757)
Career pathing (31)
CAR-T (168)
Cell therapy (461)
Cervical cancer (20)
Clinical research (66914)
Collaboration (903)
Company closure (2)
Compensation (580)
Complete response letters (19)
COVID-19 (2677)
CRISPR (47)
C-suite (263)
Cystic fibrosis (106)
Data (2382)
Decentralized trials (2)
Denatured (31)
Depression (45)
Diabetes (279)
Diagnostics (6654)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (108)
Drug shortages (27)
Duchenne muscular dystrophy (99)
Earnings (88809)
Editorial (39)
Employer branding (22)
Employer resources (151)
Events (117476)
Executive appointments (774)
FDA (18162)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (812)
Gene editing (119)
Generative AI (27)
Gene therapy (337)
GLP-1 (742)
Government (4534)
Grass and pollen (5)
Guidances (169)
Healthcare (19544)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (126)
Indications (30)
Infectious disease (2826)
Inflammatory bowel disease (147)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (103)
Interviews (324)
IPO (16875)
IRA (41)
Job creations (3822)
Job search strategy (1494)
Kidney cancer (10)
Labor market (43)
Layoffs (489)
Leadership (18)
Legal (8130)
Liver cancer (78)
Lung cancer (330)
Lymphoma (161)
Machine learning (9)
Management (62)
Manufacturing (338)
MASH (80)
Medical device (14123)
Medtech (14128)
Mergers & acquisitions (20123)
Metabolic disorders (724)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (97)
Neuropsychiatric disorders (27)
Neuroscience (1982)
NextGen: Class of 2025 (6844)
Non-profit (4618)
Now hiring (40)
Obesity (377)
Opinion (218)
Ovarian cancer (81)
Pain (92)
Pancreatic cancer (89)
Parkinson's disease (156)
Partnered (22)
Patents (256)
Patient recruitment (117)
Peanut (49)
People (59599)
Pharmaceutical (69)
Pharmacy benefit managers (20)
Phase I (21009)
Phase II (29451)
Phase III (21839)
Pipeline (1440)
Policy (149)
Postmarket research (2582)
Preclinical (9023)
Press Release (71)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (266)
Rare diseases (393)
Real estate (6235)
Recruiting (65)
Regulatory (22916)
Reports (48)
Research institute (2460)
Resumes & cover letters (361)
Rett syndrome (6)
RNA editing (6)
RSV (43)
Schizophrenia (74)
Series A (141)
Series B (93)
Service/supplier (15)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3845)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (51)
The Weekly (42)
Vaccines (732)
Venture capitalists (43)
Weight loss (243)
Women's health (37)
Worklife (16)
Date
Today (219)
Last 7 days (924)
Last 30 days (3430)
Last 365 days (33247)
2025 (12495)
2024 (36220)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (759)
Alabama (55)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (40572)
Australia (6750)
California (6633)
Canada (2096)
China (554)
Colorado (284)
Connecticut (294)
Delaware (166)
Europe (88875)
Florida (974)
Georgia (227)
Idaho (60)
Illinois (576)
India (26)
Indiana (331)
Iowa (11)
Japan (178)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (941)
Massachusetts (4979)
Michigan (249)
Minnesota (417)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (69)
New Hampshire (69)
New Jersey (1840)
New Mexico (28)
New York (1858)
North Carolina (1043)
North Dakota (9)
Northern California (2912)
Ohio (216)
Oklahoma (15)
Oregon (37)
Pennsylvania (1458)
Puerto Rico (14)
Rhode Island (34)
South America (1155)
South Carolina (26)
South Dakota (1)
Southern California (2487)
Tennessee (109)
Texas (978)
United States (24888)
Utah (195)
Virginia (157)
Washington D.C. (65)
Washington State (589)
West Virginia (3)
Wisconsin (61)
729,065 Results for "theralase technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theralase Discovers New Mechanism of Action of Lead Drug
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been Linked to Numerous Cancers and Neurogenerative Diseases
April 28, 2025
·
7 min read
Press Releases
Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson’s Patients
Parkinson’s Patients Have Improved Motor and Non-Motor Function After Treatment with Theralase(R) Cool Laser Therapy
March 10, 2025
·
12 min read
Press Releases
Theralase(R) Closes Non-Brokered Private Placement
April 14, 2025
·
5 min read
Theralase(R) Technology Effective in Virus Inactivation
Theralase Technologies Inc. is pleased to announce that it’s lead compound, Ruvidar TM, has been proven effective in the inactivation of various viruses.
June 4, 2024
·
7 min read
Press Releases
Theralase(R) Closes Non-Brokered Private Placement
March 11, 2025
·
6 min read
Press Releases
Theralase(R) Releases 2024 Annual Financial Statements
March 12, 2025
·
19 min read
Press Releases
Theralase(R) Demonstrates Effective Treatment of Herpes
February 12, 2025
·
9 min read
Press Releases
CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes
February 14, 2025
·
9 min read
Press Releases
Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin’s Lymphoma
February 25, 2025
·
7 min read
Press Releases
Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
February 11, 2025
·
7 min read
1 of 72,907
Next
